alendronate plus d3 sandoz 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet b
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 sandoz 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 iu) tablet bli
dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; gelatin; croscarmellose sodium; medium chain triglycerides; microcrystalline cellulose; magnesium stearate; sucrose; butylated hydroxytoluene - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 70 mg/70 ug apotex alendronic acid (as sodium) 70 mg and colecalciferol 70 microgram tablet blister pack
arrotex pharmaceuticals pty ltd - colecalciferol, quantity: 70 microgram; alendronate sodium, quantity: 91.37 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; mannitol; butylated hydroxytoluene; hypromellose - alendronate plus d 70 mg/70 ?g and alendronate plus d 70 mg/140 ?g tablets are indicated for the treatment of:,osteoporosis in select patients where vitamin d supplementation is recommended.,prior to treatment, osteroporosis must be confirmed by:,the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,the presence of osteoporotic fracture
genrx alendronate plus d3 70 mg/70 ug alendronic acid (as sodium) 70 mg and colecalciferol 70 microgram tablet blister pack
arrotex pharmaceuticals pty ltd - colecalciferol, quantity: 70 microgram; alendronate sodium, quantity: 91.37 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mannitol; butylated hydroxytoluene; hypromellose - alendronate plus d 70 mg/70 ?g and alendronate plus d 70 mg/140 ?g tablets are indicated for the treatment of:,osteoporosis in select patients where vitamin d supplementation is recommended.,prior to treatment, osteroporosis must be confirmed by:,the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,the presence of osteoporotic fracture
alendronate plus d3 70 mg/140 ug apotex alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 70 mg/70 ug apotex alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 iu) tablet blister pa
dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: gelatin; povidone; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; medium chain triglycerides; butylated hydroxytoluene; magnesium stearate; sucrose - alendronate plus d3 70 mg/70 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 70 mg/140 ug apotex alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet blister pack
arrotex pharmaceuticals pty ltd - colecalciferol, quantity: 140 microgram; alendronate sodium, quantity: 91.37 mg - tablet - excipient ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; butylated hydroxytoluene - alendronate plus d 70 mg/70 ?g and alendronate plus d 70 mg/140 ?g tablets are indicated for the treatment of:,osteoporosis in select patients where vitamin d supplementation is recommended.,prior to treatment, osteroporosis must be confirmed by:,the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,the presence of osteoporotic fracture
alendronate plus d3
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
fosamax plus 70 mg/140 ug alendronic acid 70 mg (as alendronate sodium) and colecalciferol 140 micrograms tablet blister pack
organon pharma pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.1387 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose; croscarmellose sodium; purified water; gelatin; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; medium chain triglycerides - the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.
fosamax plus once weekly alendronic acid 70 mg (as alendronate sodium) and colecalciferol 70 micrograms tablet blister pack
organon pharma pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.0693 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; lactose; microcrystalline cellulose; magnesium stearate; purified water; gelatin; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; medium chain triglycerides - the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.